SCHEMBL17790601

SCHEMBL17790601

C[C@@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4A3 P38919 1/20 0.56
EIF4A1 P60842 1/20 0.56
EIF4A2 Q14240 1/20 0.56
LMNA P02545 4/20 0.55
GPBAR1 Q8TDU6 3/20 0.55
CYP3A4 P08684 2/20 0.55
SHBG P04278 1/20 0.55
SERPINA6 P08185 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
CYP2C19 P33261 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CTRC Q99895 1/20 0.50
G6PD P11413 2/20 0.49
MEN1 O00255 1/20 0.49
GABRP O00591 1/20 0.49
GABRD O14764 1/20 0.49
GMNN O75496 1/20 0.49
GABRA1 P14867 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790599 1.00 EIF4A3 (0.56) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL17790606 1.00 EIF4A3 (0.56) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL17790604 1.00 EIF4A3 (0.56) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL17790603 1.00 EIF4A3 (0.56) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL17790607 1.00 EIF4A3 (0.56) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL14525637 0.88 LMNA (0.68) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL14416968 0.88 LMNA (0.68) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL14416971 0.88 LMNA (0.68) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL17361285 0.85 LMNA (0.53) EIF4A3EIF4A1EIF4A2LMNAGPBAR1
SCHEMBL20058543 0.85 LMNA (0.53) EIF4A3EIF4A1EIF4A2LMNAGPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160152658-A1 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF SAGE THERAPEUTICS, INC. 2016-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160152658-A1 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF ADRA1B, AVPR1B, ADRA2B EIF4A3 1339/4885EIF4A1 778/4885EIF4A2 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.